Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion

Diabetologia

Volumn 47, Issue 8, 2004, Pages 1437-1441

  Johansen, A ^a   Nielsen, E M D ^a   Andersen, G ^a   Hamid, Y H ^a   Jensen, D P ^a   Glumer C ^a,b   Drivsholm, T ^b   Borch Johnsen, K ^a   Jorgensen T ^b   Hansen, T ^a   Pedersen, O ^a,c  

^a STENO DIABETES CENTER   (Denmark)

^b Research Centre for Prevention and Health   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Butyrylcholinesterase; Genetic epidemiology; K variant; Mutation; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; CHOLINESTERASE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CAUCASIAN; CELL FUNCTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; DIET RESTRICTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL; POPULATION RESEARCH; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; BLOOD GLUCOSE; BUTYRYLCHOLINESTERASE; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; VARIATION (GENETICS);

EID: 4544290582     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1459-7     Document Type: Article

References (23)

1. Jaikaran ETAS, Clark A (2001) Islet amyloid and Type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta 1537:179-203
2. Pildal J, Lajer M, Hansen SK et al. (2003) Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes. Diabet Med 20:491-494
3. Tilley L, Morgan K, Kalsheker N (1998) Genetic risk factors in Alzheimer's disease. J Clin Pathol 51:293-304
4. Mesulam MM, Geula C (1994) Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol 36:722-727
5. Darvesh S, Graham DL, Hopkins DA (1998) Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation. J Comp Neurol 393:374-390
6. Sáez-Valero J, Fodero LR, Sjögren M et al. (2003) Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease. J Neurol Res 72:520-526
7. Ghebremedhin E, Thal DR, Schultz C, Braak H (2002) Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains. Neurosci Lett 320:25-28
8. Bartels CF, Jensen FS, Lockridge O et al. (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50:1086-1103
9. Yen T, Nightingale BN, Burns JC, Sullivan DR, Stewart PM (2003) Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. Clin Chem 49:1297-1308
10. Minor DL, Kim PS (1994) Measurement of the β-sheet-forming propensities of amino acids. Nature 367:660-663
11. Pepys MB, Hawkins PN, Booth DR et al. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362:553-557
12. Wiebusch H, Poirier J, Sevigny P, Schappert K (1999) Further evidence for a synergistic association between APOE E4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet 104:158-163
13. McIlroy SP, Crawford VL, Dynan KB et al. (2000) Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland. J Med Genet 37:182-185
14. Lehmann DJ, Williams J, Mcbroom J, Smith AD (2001) Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 108:541-554
15. Vionnet N, Hani EH, Dupont S et al. (2000) Genomewide search for Type 2 diabetes susceptibility genes in French Whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a Type 2 diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470-1480
16. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K (2001) Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 18:126-132
17. Glümer C, Jørgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26:2335-2340
18. WHO Study Group (1999) Report of a WHO consultation: part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
19. Ek J, Andersen G, Urhammer SA et al. (2001) Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 44:2220-2226
20. Buetow KH, Edmonson M, MacDonald R et al. (2001) High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 98:581-584
21. Hashim Y, Sheperd D, Wiltshire S et al. (2001) Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia 44:2227-2230
22. Hashim Y, Sheperd D, Wiltshire S et al. (2002) Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia 45:459 (Errata)
23. Ioannidis JPA, Trikalinos TA, Ntzani EE et al. (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567-571